Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational Study
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Betaine is a major osmolyte, also important in methyl group metabolism. Concentrations of betaine, its metabolite dimethylglycine and analog trimethylamine-N-oxide (TMAO) in blood are cardiovascular risk markers. Diabetes disturbs betaine: does diabetes alter associations between betaine-related measures and cardiovascular risk? METHODS: Plasma samples were collected from 475 subjects four months after discharge following an acute coronary admission. Death (n = 81), secondary acute MI (n = 87), admission for heart failure (n = 85), unstable angina (n = 72) and all cardiovascular events (n = 283) were recorded (median follow-up: 1804 days). RESULTS: High and low metabolite concentrations were defined as top or bottom quintile of the total cohort. In subjects with diabetes (n = 79), high plasma betaine was associated with increased frequencies of events; significantly for heart failure, hazard ratio 3.1 (1.2-8.2) and all cardiovascular events, HR 2.8 (1.4-5.5). In subjects without diabetes (n = 396), low plasma betaine was associated with events; significantly for secondary myocardial infarction, HR 2.1 (1.2-3.6), unstable angina, HR 2.3 (1.3-4.0), and all cardiovascular events, HR 1.4 (1.0-1.9). In diabetes, high TMAO was a marker of all outcomes, HR 2.7 (1.1-7.1) for death, 4.0 (1.6-9.8) for myocardial infarction, 4.6 (2.0-10.7) for heart failure, 9.1 (2.8-29.7) for unstable angina and 2.0 (1.1-3.6) for all cardiovascular events. In subjects without diabetes TMAO was only significant for death, HR 2.7 (1.6-4.8) and heart failure, HR 1.9 (1.1-3.4). Adding the estimated glomerular filtration rate to Cox regression models tended to increase the apparent risks associated with low betaine. CONCLUSIONS: Elevated plasma betaine concentration is a marker of cardiovascular risk in diabetes; conversely low plasma betaine concentrations indicate increased risk in the absence of diabetes. We speculate that the difference reflects control of osmolyte retention in tissues. Elevated plasma TMAO is a strong risk marker in diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, elevated plasma TMAO levels have been found in people at risk of CVD. These patients usually show greater concentrations of the TMAO precursors too.”
From Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target (2018) · cites this paper as [53]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In this context, it is thought that TMAO could serve as a biomarker in humans to predict prevalence of CVD and increased incidence of major adverse cardiovascular events (MACE), such as myocardial infarction, stroke and even death [7,14,52,53,54,55].”
From Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target (2018) · cites this paper as [53]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Numerous recent case–control and longitudinal studies have shown a striking association between trimethylamine N‐oxide (TMAO) levels and cardiovascular disease risks in a variety of cohorts.1, 2, 3, 4, 5, 6, 7, 8, 9, 10”
From Trimethylamine N‐Oxide Promotes Vascular Inflammation Through Signaling of Mitogen‐Activated Protein Kinase and Nuclear Factor‐κB (2016) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“In humans, recent clinical studies evidence a positive correlation between elevated plasma levels of TMAO and an increased risk for major adverse cardiovascular events.”
From Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target (2018) · cites this paper as [53]
The cited source says what the claim attributes to it.
In the citing paper
“we also performed a sensitivity analysis for the 18 data when we replaced RRs for all‐cause mortality in these publications7, 10, 22, 26; the pooled RR was 1.69 (95% CI, 1.52, 1.89; P<0.001; P heterogeneity=0.6; I2=0%).”
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y. (., Hendriksen, S., Kusek, J. W., & Van Lente, F. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,725
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597 · cited 7×
“These are not only the TMAO that is found in many fish [38], but also other substituted trimethylamines such as choline [23, 24] and carnitine [40].”
BackgroundResultInfluentialIntestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386
Cannon, C. P., Weintraub, W. S., Demopoulos, L. A., Vicari, R., Frey, M. J., Lakkis, N., Neumann, F.-J., Robertson, D. H., DeLucca, P. T., DiBattiste, P. M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106213442501 · Cited by 2,103
Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa060900 · Cited by 1,729
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
Bønaa, K. H., Njølstad, I., Ueland, P. M., Schirmer, H., Tverdal, A., Steigen, T., Wang, H., Nordrehaug, J. E., Arnesen, E., & Rasmussen, K. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055227 · Cited by 1,442 · cited 1×
“Although supplementation with folate, vitamin B12 and vitamin B6 is effective in lowering plasma homocysteine levels, these supplements have not been observed to have any effect on the risk of secondary coronary events [15–17].”
BackgroundCraig, S. A. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.3.539 · Cited by 1,062
Wang, Z., Tang, W. H. W., Buffa, J. A., Fu, X., Britt, E. B., Koeth, R. A., Levison, B. S., Fan, Y., Wu, Y., & Hazen, S. L. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu002 · Cited by 559 · cited 8×
“These are not only the TMAO that is found in many fish [38], but also other substituted trimethylamines such as choline [23, 24] and carnitine [40].”
BackgroundResultInfluentialAlbert, C. M., Cook, N. R., Gaziano, J. M., Zaharris, E., MacFadyen, J., Danielson, E., Buring, J. E., & Manson, J. E. (2008) · JAMA · doi:10.1001/jama.299.17.2027 · Cited by 511
The clinical significance of betaine, an osmolyte with a key role in methyl group metabolism
Lever, M., & Slow, S. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.03.009 · Cited by 460
Self-citation
Research works printed but not linked: 1
- Ratnam S, Wijekoon EP, Hall B, Garrow TA, Brosnan ME, et al (2006) Am J Physiol Endocrinol Metab. 290: E933– E939. 16352668
Cited by
Items 101–200 of 223
Krueger, E. S., Lloyd, T. S., & Tessem, J. S. (2021) · Nutrients · doi:10.3390/nu13082873 · Cited by 43
“Nutrients 2021, 13, 2873 2 of 29 accumulation are proposed for better CVD treatment [50,69–76].”
BackgroundInfluentialTaméz, M., Virtanen, J. K., & Lajous, M. (2016) · British Journal Of Nutrition · doi:10.1017/s000711451600146x · Cited by 41
TMAO and diabetes: from the gut feeling to the heart of the problem
Jaworska, K., Kuś, M., & Ufnal, M. (2025) · Nutrition and Diabetes · doi:10.1038/s41387-025-00377-8 · Cited by 49
“Several retrospective observational studies have demonstrated a correlation between elevated TMAO levels and an increased risk of various adverse cardiovascular outcomes in people with type 2 diabetes [38, 82, 83].”
Andraos, S., Jones, B., Lange, K., Clifford, S. A., Thorstensen, E. B., Kerr, J. A., Wake, M. A., Saffery, R., Burgner, D. P., & O'Sullivan, J. M. (2020) · Current Developments in Nutrition · doi:10.1093/cdn/nzaa179 · Cited by 40
Yadav, A. K., Verma, D., Sajwan, R. K., Poddar, M., Yadav, S. K., Verma, A. K., & Solanki, P. R. (2022) · Biosensors · doi:10.3390/bios12090733 · Cited by 43
“Recently, researchers have linked TMAO to an elevated risk of developing complex illnes es such as CVDs, colorectal cancer, chronic kidney diseases, diabetes, obesity [167,168], acute coronary syndrome [169], atherosclerosis, pneumonia, etc.”
BackgroundMetabolomic Analysis in Heart Failure
Ikegami, R., Shimizu, I., Yoshida, Y., & Minamino, T. (2017) · Circulation Journal · doi:10.1253/circj.cj-17-1184 · Cited by 40
Oral Porphyromonas gingivalis infection affects intestinal microbiota and promotes atherosclerosis
Park, S., Kim, I.-Y., Han, S. J., Kwon, S., Min, E. G., Cho, W., Koh, H., Koo, B., Lee, J., Kwon, J., et al. (2023) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13864 · Cited by 41
Winther, S. A., Oellgaard, J., Hansen, T. W., von Scholten, B. J., Reinhard, H., Ahluwalia, T. S., Wang, Z., Gæde, P., Parving, H., Hazen, S. L., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0244402 · Cited by 36
“73 m(2) [6, 30] compared to our participants with median eGFR 96 (82–104) ml/min/1.”
BackgroundDiet and Gut Microbial Function in Metabolic and Cardiovascular Disease Risk
Meyer, K. A., & Bennett, B. J. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0791-x · Cited by 38
Dietary phosphatidylcholine supplementation reduces atherosclerosis in Ldlr male mice2
Aldana-Hernández, P., Azarcoya‐Barrera, J., van der Veen, J. N., Leonard, K., Zhao, Y.-Y., Nelson, R., Goruk, S., Field, C. J., Curtis, J. M., Richard, C., et al. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108617 · Cited by 35
Liu, X., Gao, X., Zhang, R., Liu, Z., Shen, N., Di, Y., Fang, T., Li, H., & Tian, F. (2020) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2020.03.007 · Cited by 30
Rox, K., Rath, S., Pieper, D. H., Vital, M., & Brönstrup, M. (2021) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2021.03.007 · Cited by 34
“Concentrations of all four metabolites were in the same range as previously described for healthy volunteers [1,6,14,16,18].”
BackgroundMethodInfluentialArgyridou, S., Bernieh, D., Henson, J. J., Edwardson, C. L., Davies, M. J., Khunti, K., Suzuki, T., & Yates, T. E. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001359 · Cited by 38
Tian, R., Liu, H., Feng, S., Wang, H., Wang, Y., Wang, Y., Liang, L., Xu, H., Xing, H., & Zhang, S. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.01.007 · Cited by 35
Krueger, E. S., Beales, J. L., Russon, K. B., Elison, W. S., Davis, J., Hansen, J. M., Neilson, A. P., Hansen, J. M., & Tessem, J. S. (2021) · Biomolecules · doi:10.3390/biom11121892 · Cited by 33
The Interplay Between Gut Microbiota and miRNAs in Cardiovascular Diseases
Ionescu, R. F., Enache, R. M., Creţoiu, S. M., & Crețoiu, D. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.856901 · Cited by 35
Miller, P. E., Haberlen, S., Brown, T. T., Margolick, J. B., DiDonato, J. A., Hazen, S. L., Witt, M. D., Kingsley, L., Palella, F. J., Budoff, M. J., et al. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000937 · Cited by 35
Mihuţa, M. S., Paul, C., Borlea, A., Roi, C. M., Pescari, D., Velea-Barta, O.-A., Mozos, I. M., & Stoian, D. L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1253584 · Cited by 35
Alhajri, N., Khursheed, R., Ali, M. T., Izneid, T. A., Al-Kabbani, O., Al-Haidar, M. B., Al-Hemeiri, F., Alhashmi, M., & Pottoo, F. H. (2021) · Microorganisms · doi:10.3390/microorganisms9102013 · Cited by 35
Jia, X., Osborn, L. J., & Wang, Z. (2020) · Molecules · doi:10.3390/molecules25081862 · Cited by 31
Videja, M., Sevostjanovs, E., Upmale-Engela, S., Liepinsh, E., Konrāde, I., & Dambrova, M. (2022) · Nutrients · doi:10.3390/nu14051093 · Cited by 33
“Subsequently, T2D patients with elevated plasma levels of TMAO are also more susceptible to major adverse cardiovascular events, such as myocardial infarction, hospitalization for heart failure and unstable angina [13].”
BackgroundAnderson, K. M., Ferranti, E. P., Alagha, E. C., Mykityshyn, E., French, C., & Reilly, C. M. (2022) · Heart Failure Reviews · doi:10.1007/s10741-022-10254-6 · Cited by 32
“The first author of the reviewed articles was located in China [24–29], Japan [30–33], Germany [34, 35], Norway [36–38], the UK [39–44], New Zealand [45], Spain [46, 47], Denmark [48], Italy [7], Australia [49], and the USA [50–52].”
BackgroundResultInfluentialLi, D., Kirsop, J., & Tang, W. H. W. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0634-1 · Cited by 29
The Role of Gut Microbiota and Its Metabolites in Patients with Heart Failure
Cienkowski, K., Cienkowska, A., Kupczyńska, K., & Bielecka-Dabrowa, A. M. (2024) · Biomedicines · doi:10.3390/biomedicines12040894 · Cited by 31
“Moreover, a study by Lever et al. reported that serum betaine concentrations were independently associated with the risk of HF [56,57].”
BackgroundJaworska, K., Kopacz, W., Koper, M., & Ufnal, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312511 · Cited by 34
Betaine Dietary Supplementation: Healthy Aspects in Human and Animal Nutrition
Buonaiuto, G., Federiconi, A., Vecchiato, C. G., Benini, E., & Mordenti, A. L. (2025) · Antioxidants · doi:10.3390/antiox14070771 · Cited by 38
“Betaine has also demonstrated transient antihypertensive effects and improved glucose tolerance in both diabetic and non-diabetic individuals [55].”
Cardona, A., O’Brien, A., Bernier, M. C., Somogyi, Á., Wysocki, V. H., Smart, S., He, X., Ambrosio, G., Hsueh, W. A., & Raman, S. V. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000718 · Cited by 30
Andraos, S., Lange, K., Clifford, S. A., Jones, B., Thorstensen, E. B., Kerr, J. A., Wake, M. A., Saffery, R., Burgner, D. P., & O'Sullivan, J. M. (2020) · Current Developments in Nutrition · doi:10.1093/cdn/nzaa103 · Cited by 29
Quantification of choline in serum and plasma using a clinical nuclear magnetic resonance analyzer
Garcia, E., SHALAUROVA, I. Y., Matyus, S. P., Wolak, J. E., Oskardmay, D. N., & Connelly, M. A. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.11.031 · Cited by 28
Hove‐Skovsgaard, M., Gaardbo, J. C., Kolte, L., Winding, K. M., Seljeflot, I., Svardal, A. M., Berge, R. K., Gerstoft, J., Ullum, H., Trøseid, M., et al. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2334-8 · Cited by 27
“However, a larger study reported higher TMAO in persons with diabetes compared to healthy controls [20], and consensus has not been reached.”
BackgroundNakaya, K., & Ikewaki, K. (2017) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000472 · Cited by 29
Restini, C. B. A., Fink, G. D., & Watts, S. W. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105273 · Cited by 27
Wang, X., Yang, R., Zhang, W., Wang, S., Mu, H., Li, H., Dong, J., Chen, W., Yu, X. M., & Ji, F. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.09.021 · Cited by 27
Luo, L., Zhen, L., Xu, Y., Yang, Y., Feng, S., Wang, S., & Liang, S. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.03.059 · Cited by 25
Kale, D., Fatangare, A., Phapale, P. B., & Sickmann, A. (2023) · Cells · doi:10.3390/cells12242796 · Cited by 25
Zeng, Q., Zhao, M., Wang, F., Li, Y., Li, H., Zheng, J., Chen, X., Zhao, X., Liang, J., Gao, X., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.906310 · Cited by 27
Yazdekhasti, N., Brandsch, C., Schmidt, N., Schloesser, A., Huebbe, P., Rimbach, G. H., & Stangl, G. I. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500537 · Cited by 25
Liu, J. Y., Ding, L., Zhai, X., Wang, D., Xiao, C., Hui, X., Sun, T., Yu, M., Zhang, Q., Li, M., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.809642 · Cited by 31
Sriwichaiin, S., Thiennimitr, P., Thonusin, C., Sarichai, P., Buddhasiri, S., Kumfu, S., Nawara, W., Kittichotirat, W., Fucharoen, S., Chattipakorn, N., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120871 · Cited by 26
Kalagi, N. A., Thota, R. N., Stojanovski, E., Alburikan, K. A., & Garg, M. L. (2023) · Nutrients · doi:10.3390/nu15040812 · Cited by 25
The Role of the Microbiota in the Diabetic Peripheral Artery Disease
Biscetti, F., Nardella, E., Cecchini, A. L., Landolfi, R., & Flex, A. (2019) · Mediators of Inflammation · doi:10.1155/2019/4128682 · Cited by 26
Xu, X., Luo, Z., He, Y., Shan, J., Guo, J., & Li, J. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113525 · Cited by 22
Eyileten, C., Jarosz-Popek, J., Jakubik, D., Gąsecka, A., Wolska, M., Ufnal, M., Postula, M. A., Toma, A., Lang, I. M., & Siller-Matula, J. M. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.728724 · Cited by 24
Yang, G., & Zhang, X. (2021) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_12_21 · Cited by 23
“TMAO is involved in the development of atherosclerosis and has recently been associated with inflammation and obesity.[13,14] Therefore, this compound plays an important role in the obesity‐associated lipid metabolism disorders and inflammation.”
BackgroundBjørndal, B., Ramsvik, M., Lindquist, C., Nordrehaug, J., Bruheim, I., Svardal, A., Nygård, O., & Berge, R. (2015) · Marine Drugs · doi:10.3390/md13095706 · Cited by 20
“retention in tissues could be important [48].”
Chen, W., Li, Q., Hou, R., Liang, H., Zhang, Y., & Yang, Y. (2021) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2022.114711 · Cited by 26
Zhang, H., & Yao, G. (2022) · European Journal of Clinical Nutrition · doi:10.1038/s41430-022-01104-7 · Cited by 22
Li, N., Wang, Y., Zhou, J., Chen, R., Li, J., Zhao, X., Zhou, P., Liu, C., Chen, Y., Song, L., et al. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9110380 · Cited by 23
“This study found that higher TMAO levels at baseline were independently correlated to an elevated MACE risk, as the same with the previous studies focused on acute coronary syndrome or stable coronary syndrome [7,27,28].”
ResultDullaart, R. P. F., Garcia, E., Jeyarajah, E. J., Gruppen, E. G., & Connelly, M. A. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0313-5 · Cited by 20
“Thus, in view of the presently documented inverse relationship between PLTP and betaine, it seems warranted to take both factors into consideration when evaluating the extent to which they may confer cardiometabolic risk [4, 5, 18].”
Winter, M., Bretschneider, T., Thamm, S., Kleiner, C., Grabowski, D., Chandler, S., Ries, R., Kley, J. T., Fowler, D., Bartlett, C., et al. (2019) · SLAS DISCOVERY · doi:10.1177/2472555219838216 · Cited by 19
Gut Microbiota and Heart, Vascular Injury
Zeng, C., & Tan, H. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-2385-4_8 · Cited by 21
Zhang, Y., Zhang, C., Li, H., & Hou, J. (2019) · Inflammation · doi:10.1007/s10753-019-01090-2 · Cited by 17
Annunziata, G., Ciampaglia, R., Capó, X., Guerra, F., Sureda, A., Tenore, G. C., & Novellino, E. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112171 · Cited by 18
Yang, Q., Han, H., Sun, Z., Liu, L., Zheng, X., Meng, Z., Tao, N., & Liu, J. (2023) · European Journal of Clinical Investigation · doi:10.1111/eci.14041 · Cited by 17
Kijpaisalratana, N., Ament, Z., Bevers, M. B., Bhave, V. M., Guarniz, A. G., Couch, C. A., Irvin, M. R., & Kimberly, W. T. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.30446 · Cited by 19
Khan, Q. A., Asad, M., Ali, A. H., Farrukh, A. M., Naseem, U., Semakieh, B., Levin-Carrion, Y., & Afzal, M. (2024) · Medicine · doi:10.1097/md.0000000000037825 · Cited by 21
Liu, J., Ge, P., Luo, Y., Sun, Z., Luo, X., Li, H., Pei, B., Xun, L., Zhang, X., Jiang, Y., et al. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s512207 · Cited by 24
Mehta, V., Nagu, P., Inbaraj, B. S., Sharma, M., Parashar, A., & Sridhar, K. (2022) · Bioengineering · doi:10.3390/bioengineering9120798 · Cited by 18
Mechanism of actions of probiotics on type 2 diabetes: Development and complications
Ağagündüz, D., Çelik, E., Cemali, Ö., Yeşildemir, Ö., Demirci, K. Ş., Akkuş, G., Esatbeyoglu, T., & Özoğul, F. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118421 · Cited by 21
Subramaniam, S., Boukhlouf, S., & Fletcher, C. (2019) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000000838 · Cited by 15
A molecular interplay for osmolytes-induced phase behaviour of poly (vinyl methyl ether)
Narang, P., & Venkatesu, P. (2017) · Polymer · doi:10.1016/j.polymer.2017.10.048 · Cited by 15
Paul, A., Azhar, S., Das, P. N., Bairagi, N., & Chatterjee, S. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105365 · Cited by 16
Yu, H., Li, L., Deng, Y., Zhang, G., Jiang, M., Huang, H., Li, C., Lv, Z., Zhou, Y., & Liu, X. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.903828 · Cited by 15
Cheng, E., Hung, S., & Lin, T. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.12.001 · Cited by 21
Li, Z., Hui, J., Li, S., Cao, T., Zhang, J., Mao, X., Wang, F., Wang, F., He, P., You, Y.-P., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15249 · Cited by 19
“Previous studies have shown that patients with type 2 diabetes mellitus (DM) have increased TMAO concentrations compared to non-diabetic patients [ 13– 16 ].”
BackgroundGao, X., Jiang, C., Xu, J., Yanagita, T., Xue, C., & Wang, Y. (2016) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2016.1206813 · Cited by 15
Yang, Y., Xu, J., Zhou, J., Xue, J., Gao, J., Li, X., Sun, B., Yang, B., Liu, Z., Zhao, Z., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.852009 · Cited by 15
Wilson, S. M. G., Peach, J. T., Fausset, H., Miller, Z. J., Walk, S. T., Yeoman, C. J., Bothner, B. B., & Miles, M. P. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1244692 · Cited by 17
Yang, Y., Han, Z., Wang, Y., Wang, L., Pan, S., Liang, S., & Wang, S. (2015) · RSC Advances · doi:10.1039/c5ra00823a · Cited by 13
Buawangpong, N., Pinyopornpanish, K., Phrommintikul, A., Chindapan, N., Devahastin, S., Chattipakorn, N., & Chattipakorn, S. C. (2022) · Food & Function · doi:10.1039/d2fo02021a · Cited by 12
Trimethylamine N-Oxide as a Potential Risk Factor for Non-communicable Diseases: A Systematic Review
Tavassol, Z. H., Ejtahed, H., Larijani, B. A., & Hasani‐Ranjbar, S. (2022) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666221103120410 · Cited by 12
Lim, A. S., Cruz, S. N., Uddin, A. A., Malysheva, O., Caudill, M. A., Alonso, C., Montilla, A., Karsdal, M. A., Leeming, D. J., Mayorca‐Guiliani, A. E., et al. (2025) · Hepatology · doi:10.1097/hep.0000000000001477 · Cited by 13
The origin of trimethylamine- N-oxide (TMAO) and its role in development of atherosclerosis
He, Z., & Chen, Z. (2018) · Journal of Food Bioactives · doi:10.31665/jfb.2018.2138 · Cited by 14
“Moreover, high plasma betaine and TMAO concentrations were shown to be markers of cardiovascular risk in diabetic patients, whereas low plasma betaine concentrations suggested the increased risk of CVD in the absence of diabetes (Lever et al. 2014).”
BackgroundAssociation of Gut Microbiota-Related Metabolites and Type 2 Diabetes in Two Puerto Rican Cohorts
Sawicki, C. M., Pacheco, L. S., Rivas‐Tumanyan, S., Cao, Z., Haslam, D. E., Liang, L., Tucker, K. L., JOSHIPURA, K. J., & Bhupathiraju, S. N. (2024) · Nutrients · doi:10.3390/nu16070959 · Cited by 10
Blaak, E. E., & Canfora, E. E. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.11.11 · Cited by 9
Chen, Y., Fang, S., Liu, H., Zheng, H., He, Y., Chen, Z., Chen, M., Zhang, G., & Zhou, H. (2018) · International Biodeterioration & Biodegradation · doi:10.1016/j.ibiod.2018.09.005 · Cited by 10
Tahara, A., Tahara, N., Yamagishi, S., Honda, A., Igata, S., Nitta, Y., Bekki, M., Nakamura, T., Sugiyama, Y., Sun, J., et al. (2017) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2017.1318117 · Cited by 10
“and predicted future adverse cardiovascular events and mortality in patients with diabetes, chronic kidney disease or coronary artery disease after adjustment for traditional risk factors as well (Lever et al. 2014; Mueller et al. 2015; Stubbs et al. 2016; Tang et al. 2013).”
BackgroundKim, D. W., Kim, H. J., Seong, E. Y., Kim, S. S., Lee, S., Kim, S., Kwon, C. H., & Song, S. H. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110986 · Cited by 9
Mohammadi, S., Eslami, M., Pourghazi, F., Ejtahed, H., Shahrestanaki, E., Qorbani, M., Hasani‐Ranjbar, S., & Larijani, B. A. (2025) · Obesity Reviews · doi:10.1111/obr.13963 · Cited by 13
“…( n = 9) [15–17, 27, 34, 38, 44, 45, 48], United States ( n = 5) [24, 28, 30, 37, 39], Spain ( n = 2) [32, 46], Germany ( n = 2) [33, 47], Austria ( n = 2) [31, 40], and one study each from Canada [42], Netherlands [41], New Zealand [29], United Kingdom [36], Saudi Arabia [43], and Japan [35].”
Zhang, C., He, J., Huo, Y., Liu, L., Xie, Y., Meng, Y., Wei, G., Deng, L., Jiang, Y., & Feng, J. (2025) · Nutrition Journal · doi:10.1186/s12937-025-01159-9 · Cited by 11
Liu, Y., Dong, G., Huang, K., Ye, H., Chen, X., Zhu, M., Hao, X.-Q., Ni, Y., & Fu, J. (2023) · Pediatric Diabetes · doi:10.1155/2023/6003102 · Cited by 14
“TMAO is confirmed as a strong risk marker in diabetes and its related complications [49].”
Narang, P., de Oliveira, T. E., Venkatesu, P., & Netz, P. A. (2020) · Physical Chemistry Chemical Physics · doi:10.1039/c9cp06683g · Cited by 8
TMAO Impairs Mouse Aortic Vasodilation by Inhibiting TRPV4 Channels in Endothelial Cells
Zhang, N., Liu, L., Lv, X., Wang, Y., Zhang, W., Wen, X., Fan, Y., & Zhou, T. (2024) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-024-10543-5 · Cited by 8
Mechanisms Whereby Whole Grain Cereals Modulate the Prevention of Type 2 Diabetes
Knudsen, K. E. B., Hartvigsen, M. L., Hedemann, M. S., & Hermansen, K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801585-8.00008-7 · Cited by 12
Dietary Whole Egg Reduces Body Weight Gain in a Dose-Dependent Manner in Zucker Diabetic Fatty Rats
Saande, C. J., Webb, J. L., Curry, P., Rowling, M. J., & Schalinske, K. L. (2019) · Journal of Nutrition · doi:10.1093/jn/nxz143 · Cited by 8
Effects of gut microbial metabolite trimethylamine N-oxide (TMAO) on platelets and endothelial cells
Krüger‐Genge, A., Jung, F., Hufert, F. T., Jung, F., Küpper, J. ‐., & Storsberg, J. (2020) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-209206 · Cited by 10
Farràs, M., Swann, J. R., Rowland, I. R., Rubió, L., Subirana, I., Catalán, Ú., Motilva, M., Solà, R., Covas, M. I., Blanco‐Vaca, F., et al. (2022) · Antioxidants · doi:10.3390/antiox11101964 · Cited by 8
Archaebiotics: Archaea as Pharmabiotics for Treating Chronic Disease in Humans?
Hania, W. B., Ballet, N., Vandekerckove, P., Ollivier, B., O’Toole, P. W., & Brugère, J. (2017) · InTech eBooks · doi:10.5772/intechopen.69945 · Cited by 9
“Also, type 2 diabetes (T2D) is associated with higher pTMAO levels [27], but until now, it is still unclear if this is due to a confounding action with glycaemic control or renal function.”
Canyelles, M., Pérez, A., Junza, A., Miñambres, I., Yanes, Ó., Sardà, H., Rotllán, N., Julve, J., Benítez, S., Sánchez‐Quesada, J. L., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12112783 · Cited by 6
“Furthermore, two reports found that higher circulating TMAO concentrations were independently associated with the risk of future cardiovascular events and mortality in T2D patients [16,17].”
BackgroundSharifi‐Zahabi, E., Soltani, S., Asiaei, S., Dehesh, P., Mohsenpour, M. A., & Shidfar, F. (2024) · Nutrition Research · doi:10.1016/j.nutres.2024.09.002 · Cited by 6
Gut Microbiota and Type 2 Diabetes Mellitus
Longo, S., Menghini, R., & Federici, M. (2023) · Endocrinology · doi:10.1007/978-3-031-08115-6_8-1 · Cited by 6
Ji, X., Zhang, X., Zhang, J., Niu, S., Xiao, H., Chen, H., & Qu, C. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1498502 · Cited by 5
Yongxia, Y., Xi, C., Shumei, W., Wang, Z., Li, J., & Shengwang, L. (2017) · 中医杂志:英文版 · doi:10.1016/s0254-6272(17)30069-9 · Cited by 5
Manasieva, V., Thakur, S., Lione, L. A., Baydoun, A. R., & Skamarauskas, J. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054946 · Cited by 4
Hamad, A., Özkan, M. H., & Uma, S. (2021) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b20-00767 · Cited by 5
Trimethylamine Oxide (TMAO): A New Toxic Kid on the Block
Subramaniam, S. (2018) · Journal of Biomolecular Research & Therapeutics · doi:10.4172/2167-7956.1000e159 · Cited by 4
Metabolomic profiles of an atherogenic TMAO-dietary pattern among postmenopausal women
Burns, K. F., Blair, R. H., LaMonte, M. J., Wactawski‐Wende, J., Rexrode, K. M., Balasubramanian, R., Tabung, F. K., Snetselaar, L. G., & Millen, A. E. (2025) · European Journal of Nutrition · doi:10.1007/s00394-025-03792-w · Cited by 3
Gut Microbiota and Gut-Brain Axis in Health and Disease A Narrative Review
Wasiak, J., Zielonka, K., Dądela, B., Markowski, M., Śliwa, N., Majewska, E. M., Kawalska, E., Gnitecki, S., Janczura, S., & Borowski, M. (2025) · Quality in Sport · doi:10.12775/qs.2025.41.60102 · Cited by 3
“TMAO is considered a potential biomarker for predicting the likelihood of CVD and the risk of major adverse cardiovascular events (MACE), such as heart attack, stroke, and mortality (Lever et al., 2014; Mente et al., 2015; Trøseid et al., 2015) .”
Gut Microbiota and Type 2 Diabetes Mellitus
Longo, S., Menghini, R., & Federici, M. (2024) · Endocrinology · doi:10.1007/978-3-031-35064-1_8 · Cited by 4
Biomarkers (plasma trimethylamine- N -oxide) to predict atrial fibrillation: Are we there yet?
Chelu, M. G., & Li, N. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.05.106 · Cited by 3
Metadata
- Authors
- Lever, M., George, P. M., Slow, S., Bellamy, D., Young, J. M., Ho, M., McEntyre, C. J., Elmslie, J. L., Atkinson, W., Molyneux, S. L., Troughton, R. W., Frampton, C. M., Richards, A. M., & Chambers, S. T.
- Affiliations
- Canterbury Health Laboratories (NZ)
- University of Otago (NZ)
- Corresponding author
- Lever, Michael
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-12-10
- Volume
- 9
- Issue
- 12
- Pages
- e114969
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4262445
- OpenAlex
- W2045387428
- Cited by
- 223
- References
- 43
- Citations by year
- 2026: 3 · 2025: 15 · 2024: 15 · 2023: 14 · 2022: 29 · 2021: 25 · 2020: 32 · 2019: 19 · 2018: 12 · 2017: 25 · 2016: 21 · 2015: 13
- FWCI
- 16.32
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Maurice and Phyllis Paykel Trust
- Health Research Council of New Zealand (02/152)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- betaine, trimethylamine N-oxide, dimethylglycine, cardiovascular risk markers, diabetes mellitus, heart failure, myocardial infarction, unstable angina, cardiovascular mortality, acute coronary syndrome, estimated glomerular filtration rate, plasma metabolites, methyl group metabolism, osmolytes, risk stratification, risk prediction model
- MeSH terms
- Aged, Aged, 80 and over, Betaine, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Humans, Male, Methylamines, Middle Aged, Risk Factors, Biomarkers, Proportional Hazards Models, Case-Control Studies, Kaplan-Meier Estimate, Acute Coronary Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.